The Pharmacokinetics and Bioavailability of Prochlorperazine Delivered as a Thermally Generated Aerosol in a Single Breath to Volunteers
Authors:
- 1 October 2008
- journal article
- clinical trial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 85 (1) , 71-77
Abstract
A thermally generated aerosol (TGA) system can effect reliable delivery of excipient-free drug to alveoli, resulting in rapid systemic drug absorption. We developed a pharmacokinetic model of prochlorperazine, administered by inhalation and as a rapid intravenous infusion, and we determined absolute TGA bioavailability in eight healthy volunteers in this institutional review board-approved, two-period crossover study. After the drug was administered as either a 5-s intravenous infusion or a TGA single-breath inhalation, blood was collected at various times for up to 24 h. Plasma prochlorperazine concentrations were measured using liquid chromatography-tandem mass spectrometry. Inhalation and rapid intravenous administration produced similar plasma prochlorperazine concentration profiles. Intravenous and inhalation pharmacokinetics were well characterized by a simultaneous two-compartment model with multiple absorption delays. Prochlorperazine pharmacokinetic parameters were similar to those reported for single intravenous doses. The geometric mean bioavailability after TGA delivery was 1.10. The administration of prochlorperazine by inhalation resulted in pharmacokinetics similar to that seen after intravenous administration, in terms of speed, extent, and consistency of absorption.Keywords
This publication has 33 references indexed in Scilit:
- Inhaling medicines: delivering drugs to the body through the lungsNature Reviews Drug Discovery, 2007
- Ultra-Fast Absorption of Amorphous Pure Drug Aerosols via Deep Lung InhalationJournal of Pharmaceutical Sciences, 2006
- β-Adrenergic Blockade Affects Initial Drug Distribution Due to Decreased Cardiac Output and Altered Blood Flow DistributionThe Journal of Pharmacology and Experimental Therapeutics, 2004
- A Modified Two-Portion Absorption Model to Describe Double-Peak Absorption Profiles of RanitidineClinical Pharmacokinetics, 2003
- Enterohepatic CirculationClinical Pharmacokinetics, 2002
- Randomized, Placebo-Controlled Evaluation of Prochlorperazine Versus Metoclopramide for Emergency Department Treatment of Migraine HeadacheAnnals of Emergency Medicine, 1995
- A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1989
- Pharmacokinetics of Lignocaine and Bupivacaine in Surgical Patients Following Epidural AdministrationClinical Pharmacokinetics, 1987
- A Time-Lag Model for Pharmacokinetics of Drugs Subject to Enterohepatic CirculationJournal of Pharmaceutical Sciences, 1982
- Drug distribution as a function of binding competition. Experiments with the distribution dialysis techniqueJournal of Pharmacy and Pharmacology, 1980